Significance of nitric oxide synthases: Lessons from triple nitric oxide synthases null mice

Journal of Pharmacological Sciences

Volumn 127, Issue 1, 2015, Pages 42-52

  Tsutsui, Masato ^a   Tanimoto, Akihide ^b   Tamura, Masahito ^c   Mukae, Hiroshi ^c   Yanagihara, Nobuyuki ^c   Shimokawa, Hiroaki ^d   Otsuji, Yutaka ^c  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^d TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cardiovascular disease; Metabolic disease; Myocardial infarction; Nitric oxide synthase; Null mice

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE;

ARTERIOSCLEROSIS; BONE DENSITY; BONE TURNOVER; CARDIOVASCULAR SYSTEM; DIASTOLIC HEART FAILURE; DYSLIPIDEMIA; ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE; ENZYME ACTIVITY; HEART INFARCTION; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERPOLARIZATION; HYPERTENSION; INDUCIBLE NITRIC OXIDE SYNTHASE GENE; KIDNEY DISEASE; LUNG FIBROSIS; METABOLIC SYNDROME X; MOLECULAR PATHOLOGY; MOUSE MODEL; MUSCULOSKELETAL SYSTEM; NEPHROGENIC DIABETES INSIPIDUS; NEURONAL NITRIC OXIDE SYNTHASE GENE; NONHUMAN; PROTEIN EXPRESSION; RESPIRATORY SYSTEM; REVIEW; SURVIVAL RATE; ANIMAL; BONE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; DISEASE MODEL; ENZYMOLOGY; GENETICS; KNOCKOUT MOUSE; METABOLIC DISORDER; METABOLISM; MOUSE;

ANIMALS; BONE AND BONES; CARDIOVASCULAR DISEASES; DISEASE MODELS, ANIMAL; HUMANS; METABOLIC DISEASES; MICE; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE; PULMONARY FIBROSIS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84924056460     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1016/j.jphs.2014.10.002     Document Type: Review

References (68)

1. H. Shimokawa, and M. Tsutsui Nitric oxide synthases in the pathogenesis of cardiovascular disease: lessons from genetically modified mice Pflugers Archiv 459 2010 959 967
2. M. Tsutsui, S. Nakata, H. Shimokawa, Y. Otsuji, and N. Yanagihara Spontaneous myocardial infarction and nitric oxide synthase Trends Cardiovasc Med 18 2008 275 279
3. M. Tsutsui, H. Shimokawa, Y. Otsuji, Y. Ueta, Y. Sasaguri, and N. Yanagihara Nitric oxide synthases and cardiovascular diseases: insights from genetically modified mice Circ J 73 2009 986 993
4. M. Tsutsui, H. Shimokawa, Y. Otsuji, and N. Yanagihara Pathophysiological relevance of NO signaling in the cardiovascular system: novel insight from mice lacking all NO synthases Pharmacol Ther 128 2010 499 508
5. D.M. Dudzinski, J. Igarashi, D. Greif, and T. Michel The regulation and pharmacology of endothelial nitric oxide synthase Annu Rev Pharmacol Toxicol 46 2006 235 276
6. U. Forstermann, J.P. Boissel, and H. Kleinert Expressional control of the 'constitutive' isoforms of nitric oxide synthase (NOS I and NOS III) FASEB J 12 1998 773 790
7. S. Nakata, M. Tsutsui, H. Shimokawa, M. Tamura, H. Tasaki, and T. Morishita Vascular neuronal NO synthase is selectively upregulated by platelet-derived growth factor Arterioscler Thromb Vasc Biol 25 2005 2502 2508
8. S. Nakata, M. Tsutsui, H. Shimokawa, T. Yamashita, A. Tanimoto, and H. Tasaki Statin treatment upregulates vascular neuronal nitric oxide synthase through Akt/NF-kappaB pathway Arterioscler Thromb Vasc Biol. 27 2007 92 98
9. M. Tsutsui Neuronal nitric oxide synthase as a novel anti-atherogenic factor Journal of Atherosclerosis and Thrombosis 11 2004 41 48
10. I.B. Buchwalow, T. Podzuweit, W. Bocker, V.E. Samoilova, S. Thomas, and M. Wellner Vascular smooth muscle and nitric oxide synthase FASEB Journal 16 2002 500 508
11. C.S. Park, R. Park, and G. Krishna Constitutive expression and structural diversity of inducible isoform of nitric oxide synthase in human tissues Life Sci 59 1996 219 225
12. J.N. Wilcox, R.R. Subramanian, C.L. Sundell, W.R. Tracey, J.S. Pollock, and D.G. Harrison Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels Arterioscler Thromb Vasc Biol 17 1997 2479 2488
13. I.L.O. Buxton, D.J. Cheek, D. Eckman, D.P. Westfall, K.M. Sanders, and K.D. Keef NG-nitro-L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists Circ Res. 72 1993 387 395
14. K.F. Heim, G. Thomas, and P.W. Ramwell Effect of substituted arginine compounds on superoxide production in the rabbit aorta J Pharmacol Exp Ther 257 1991 1130 1135
15. D.A. Peterson, D.C. Peterson, S. Archer, and E.K. Weir The nonspecificity of specific nitric oxide synthase inhibitors Biochem Biophys Res Commun 187 1992 797 801
16. G. Thomas, and P.W. Ramwell NÉ÷-nitro-L-arginine benzyl ester, a potent irreversible inhibitor of endothelium dependent relaxation Biochem Biophys Res Commun 179 1991 1677 1682
17. O. Suda, M. Tsutsui, T. Morishita, A. Tanimoto, M. Horiuchi, and H. Tasaki Long-term treatment with N(omega)-nitro-L-arginine methyl ester causes arteriosclerotic coronary lesions in endothelial nitric oxide synthase-deficient mice Circulation 106 2002 1729 1735
18. O. Suda, M. Tsutsui, T. Morishita, H. Tasaki, S. Ueno, and S. Nakata Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice Arterioscler Thromb Vasc Biol. 24 2004 1682 1688
19. H. Duplain, R. Burcelin, C. Sartori, S. Cook, M. Egli, and M. Lepori Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase Circulation 104 2001 342 345
20. D.S. Bredt, and S.H. Snyder Nitric oxide: a physiological messenger molecule Annu Rev Biochem 63 1994 175 195
21. R.F. Furchgott The role of endothelium in the responses of vascular smooth muscle to drugs Annu Rev Pharmacol Toxicol 24 1984 175 197
22. L.J. Ignarro Biosynthesis and metabolism of endothelium-derived nitric oxide Annu Rev Pharmacol Toxicol 30 1990 535 560
23. S. Moncada, R.M.J. Palmer, and E.A. Higgs Nitric oxide: physiology, pathophysiology, and pharmacology Pharmacol Rev. 43 1991 109 142
24. F. Murad What are the molecular mechanisms for the antiproliferative effects of nitric oxide and cGMP in vascular smooth muscle? Circulation 95 1997 1101 1103
25. H. Shimokawa Primary endothelial dysfunction: atherosclerosis J Mol Cell Cardiol 31 1999 23 37
26. M. Moroi, L. Zhang, T. Yasuda, R. Virmani, H.K. Gold, and M.C. Fishman Interaction of genetic deficiency of endothelial nitric oxide, gender, and pregnancy in vascular response to injury in mice J Clin Invest 101 1998 1225 1232
27. H. Son, R.D. Hawkins, K. Martin, M. Kiebler, P.L. Huang, and M.C. Fishman Long-term potentiation is reduced in mice that are doubly mutant in endothelial and neuronal nitric oxide synthase Cell. 87 1996 1015 1023
28. A. Huang, D. Sun, E.G. Shesely, E.M. Levee, A. Koller, and G. Kaley Neuronal NOS-dependent dilation to flow in coronary arteries of male eNOS-KO mice Am J Physiol Heart Circ Physiol 282 2002 H429 436
29. K.G. Lamping, D.W. Nuno, E.G. Shesely, N. Maeda, and F.M. Faraci Vasodilator mechanisms in the coronary circulation of endothelial nitric oxide synthase-deficient mice Am J Physiol Heart Circ Physiol 279 2000 H1906 1912
30. T. Morishita, M. Tsutsui, H. Shimokawa, K. Sabanai, H. Tasaki, and O. Suda Nephrogenic diabetes insipidus in mice lacking all nitric oxide synthase isoforms Proc Natl Acad Sci U S A 102 2005 10616 10621
31. P.A. Ortiz, and J.L. Garvin Cardiovascular and renal control in NOS-deficient mouse models Am J Physiol Regul Integr Comp Physiol 284 2003 R628 638
32. T. Morishita, M. Tsutsui, H. Shimokawa, M. Horiuchi, A. Tanimoto, and O. Suda Vasculoprotective roles of neuronal nitric oxide synthase FASEB Journal 16 2002 1994 1996
33. S. Nakata, M. Tsutsui, H. Shimokawa, O. Suda, T. Morishita, and K. Shibata Spontaneous myocardial infarction in mice lacking all nitric oxide synthase isoforms Circulation 117 2008 2211 2223
34. Y. Sasaguri, K.Y. Wang, A. Tanimoto, M. Tsutsui, H. Ueno, and Y. Murata Role of histamine produced by bone marrow-derived vascular cells in pathogenesis of atherosclerosis Circ Res. 96 2005 974 981
35. Y. Furuno, T. Morishita, Y. Toyohira, S. Yamada, S. Ueno, and N. Morisada Crucial vasculoprotective role of the whole nitric oxide synthase system in vascular lesion formation in mice: involvement of bone marrow-derived cells Nitric Oxide 25 2011 350 359
36. P. Laine, M. Kaartinen, A. Penttila, P. Panula, T. Paavonen, and P.T. Kovanen Association between myocardial infarction and the mast cells in the adventitia of the infarct-related coronary artery Circulation 99 1999 361 369
37. T. Ninomiya, Y. Kiyohara, M. Kubo, Y. Tanizaki, Y. Doi, and K. Okubo Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study Kidney Int 68 2005 228 236
38. T. Ninomiya, Y. Kiyohara, Y. Tokuda, Y. Doi, H. Arima, and A. Harada Impact of kidney disease and blood pressure on the development of cardiovascular disease: an overview from the Japan Arteriosclerosis Longitudinal Study Circulation 118 2008 2694 2701
39. T. Shoji, T. Abe, H. Matsuo, G. Egusa, Y. Yamasaki, and N. Kashihara Chronic kidney disease, dyslipidemia, and atherosclerosis Journal of Atherosclerosis and Thrombosis 19 2012 299 315
40. S. Miyazaki-Anzai, M. Levi, A. Kratzer, T.C. Ting, L.B. Lewis, and M. Miyazaki Farnesoid X receptor activation prevents the development of vascular calcification in ApoE-/- mice with chronic kidney disease Circ Res. 106 2010 1807 1817
41. C.C. Pelletier, L. Koppe, M.L. Croze, E. Kalbacher, R.E. Vella, and F. Guebre-Egziabher White adipose tissue overproduces the lipid-mobilizing factor zinc alpha2-glycoprotein in chronic kidney disease Kidney Int 83 2013 878 886
42. T. Uchida, Y. Furuno, A. Tanimoto, Y. Toyohira, K. Arakaki, and M. Kina-Tanada Development of an experimentally useful model of acute myocardial infarction: 2/3 nephrectomized triple nitric oxide synthases-deficient mouse J Moll Cell Cardiol 77 2014 29 41
43. K. Shibata, Y. Yatera, Y. Furuno, K. Sabanai, N. Morisada, and S. Nakata Spontaneous development of left ventricular hypertrophy and diastolic dysfunction in mice lacking all nitric oxide synthases Circ J 74 2010 2681 2692
44. J. Ishikawa, S. Ishikawa, T. Kabutoya, T. Gotoh, K. Kayaba, and J.E. Schwartz Cornell product left ventricular hypertrophy in electrocardiogram and the risk of stroke in a general population Hypertension 53 2009 28 34
45. K. Nakamura, T. Okamura, T. Hayakawa, T. Kadowaki, Y. Kita, and A. Okayama Electrocardiogram screening for left high R-wave predicts cardiovascular death in a Japanese community-based population: NIPPON DATA90 Hypertension Res. 29 2006 353 360
46. F. Kamezaki, M. Tsutsui, M. Takahashi, S. Sonoda, T. Kubo, and Y. Fujino Plasma levels of nitric oxide metabolites are markedly reduced in normotensive men with electrocardiographically determined left ventricular hypertrophy Hypertension 64 2014 516 522
47. K.K. Ho, J.L. Pinsky, W.B. Kannel, and D. Levy The epidemiology of heart failure: the Framingham Study J Am Coll Cardiol 22 1993 6A 13A
48. K. Yamamoto, Y. Sakata, T. Ohtani, Y. Takeda, and T. Mano Heart failure with preserved ejection fraction Circ J 73 2009 404 410
49. M.R. Zile, and D.L. Brutsaert New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function Circulation 105 2002 1387 1393
50. T. Matoba, H. Shimokawa, H. Kubota, K. Morikawa, T. Fujiki, and I. Kunihiro Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in human mesenteric arteries Biochem Biophys Res Commun 290 2002 909 913
51. T. Matoba, H. Shimokawa, M. Nakashima, Y. Hirakawa, Y. Mukai, and K. Hirano Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice [In Process Citation] J Clin Invest 106 2000 1521 1530
52. A. Takaki, K. Morikawa, M. Tsutsui, Y. Murayama, E. Tekes, and H. Yamagishi Crucial role of nitric oxide synthases system in endothelium-dependent hyperpolarization in mice J Exp Med 205 2008 2053 2063
53. T. Kadowaki, T. Yamauchi, N. Kubota, K. Hara, K. Ueki, and K. Tobe Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome J Clin Invest 116 2006 1784 1792
54. Y. Matsuzawa, T. Funahashi, S. Kihara, and I. Shimomura Adiponectin and metabolic syndrome Arterioscler Thromb Vasc Biol. 24 2004 29 33
55. K. Shioji, S. Moriwaki, Y. Takeuchi, T. Uegaito, S. Mutsuo, and M. Matsuda Relationship of serum adiponectin level to adverse cardiovascular events in patients who undergo percutaneous coronary intervention Circ J 71 2007 675 680
56. Y. Yatera, K. Shibata, Y. Furuno, K. Sabanai, N. Morisada, and S. Nakata Severe Dyslipidemia, Atherosclerosis, and Sudden Cardiac Death in Mice Lacking All NO Synthases Fed a High-Fat Diet Cardiovasc Res. 87 2010 675 682
57. X. Hua, C. Yokoyama, J. Wu, M.R. Briggs, M.S. Brown, and J.L. Goldstein SREBP-2, a second basic-helix-loop-helix-leucine zipper protein that stimulates transcription by binding to a sterol regulatory element Proc Natl Acad Sci U S A 90 1993 11603 11607
58. A. Miyajima, J. Chen, D.P. Poppas, E.D. Vaughan Jr., and D. Felsen Role of nitric oxide in renal tubular apoptosis of unilateral ureteral obstruction Kidney Int 59 2001 1290 1303
59. J.J. Morrissey, S. Ishidoya, R. McCracken, and S. Klahr Nitric oxide generation ameliorates the tubulointerstitial fibrosis of obstructive nephropathy J Am Soc Nephrol 7 1996 2202 2212
60. G.S. Kuncio, E.G. Neilson, and T. Haverty Mechanisms of tubulointerstitial fibrosis Kidney Int 39 1991 550 556
61. N. Morisada, M. Nomura, H. Nishii, Y. Furuno, M. Sakanashi, and K. Sabanai Complete disruption of all nitric oxide synthase genes causes markedly accelerated renal lesion formation following unilateral ureteral obstruction in mice in vivo J Pharmacol Sci. 114 2010 379 389
62. S. Noguchi, K. Yatera, K.Y. Wang, K. Oda, K. Akata, and K. Yamasaki Nitric oxide exerts protective effects against bleomycin-induced pulmonary fibrosis in mice Respir Res. 15 2014 92
63. J.A. Riancho, E. Salas, M.T. Zarrabeitia, J.M. Olmos, J.A. Amado, and J.L. Fernandez-Luna Expression and functional role of nitric oxide synthase in osteoblast-like cells J Bone Miner Res. 10 1995 439 446
64. H. MacPherson, B.S. Noble, and S.H. Ralston Expression and functional role of nitric oxide synthase isoforms in human osteoblast-like cells Bone 24 1999 179 185
65. M.L. Brandi, M. Hukkanen, T. Umeda, N. Moradi-Bidhendi, S. Bianchi, and S.S. Gross Bidirectional regulation of osteoclast function by nitric oxide synthase isoforms Proc Natl Acad Sci U S A 92 1995 2954 2958
66. T.P. Kasten, P. Collin-Osdoby, N. Patel, P. Osdoby, M. Krukowski, and T.P. Misko Potentiation of osteoclast bone-resorption activity by inhibition of nitric oxide synthase Proc Natl Acad Sci U S A 91 1994 3569 3573
67. K. Sabanai, M. Tsutsui, A. Sakai, H. Hirasawa, S. Tanaka, and E. Nakamura Genetic disruption of all NO synthase isoforms enhances BMD and bone turnover in mice in vivo: involvement of the renin-angiotensin system J Bone Miner Res. 23 2008 633 643
68. H. Kubota, K. Noguchi, T. Matsuzaki, F. Hattori, M. Sakanashi, and M. Kina-Tanada Complete disruption of all nitric oxide synthase genes markedly reduces cerebral infarct size after middle cerebral artery occlusion in mice Circ J 78 Suppl. I 2014 I-853